Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | LA |
Sever Pain in Left Arm at injection site 3 months later; This non-serious case was reported by a consumer and described the occurrence of injection site pain in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 29-DEC-2024, the patient received the 1st dose of Shingrix (left arm). On 29-DEC-2024, less than a day after receiving Shingrix, the patient experienced injection site pain (Verbatim: Sever Pain in Left Arm at injection site 3 months later). The outcome of the injection site pain was not resolved. It was unknown if the reporter considered the injection site pain to be related to Shingrix. It was unknown if the company considered the injection site pain to be related to Shingrix. Additional Information: GSK receipt date: 14-MAR-2025 Consumer reported that he took the first dose of Shingrix vaccine and experienced severe pain in left arm at injection site 3 months later. Reporter also mentioned that they did not want to get second shot because of ongoing pain from first shot.